Benralizumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12023 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 38 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | thrombocytopenia due to immune destruction | KG + DL |
| 2 | dermatitis | KG + DL |
| 3 | acne keloid | KG + DL |
| 4 | neonatal dermatomyositis | KG + DL |
| 5 | amyopathic dermatomyositis | KG + DL |
| 6 | acrodermatitis chronica atrophicans | KG + DL |
| 7 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 8 | hydroa vacciniforme, familial | KG + DL |
| 9 | autoimmune thrombocytopenic | KG + DL |
| 10 | Evans syndrome | KG + DL |
| 11 | autosomal thrombocytopenia with normal platelets | KG + DL |
| 12 | primary release disorder of platelets | KG + DL |
| 13 | neonatal thrombocytopenia | KG + DL |
| 14 | pseudo-von Willebrand disease | KG + DL |
| 15 | mixed-type autoimmune hemolytic anemia | KG + DL |
| 16 | drug-induced autoimmune hemolytic anemia | KG + DL |
| 17 | Glanzmann thrombasthenia | KG + DL |
| 18 | neonatal autoimmune hemolytic anemia | KG + DL |
| 19 | proteinuria | KG + DL |
| 20 | filariasis | KG + DL |
| 21 | severe nonproliferative diabetic retinopathy | KG + DL |
| 22 | paroxysmal nocturnal hemoglobinuria | KG + DL |
| 23 | primary CD59 deficiency | KG + DL |
| 24 | syndromic constitutional thrombocytopenia | KG + DL |
| 25 | Ledderhose disease | KG + DL |
| 26 | infantile digital fibromatosis | KG + DL |
| 27 | penile fibromatosis | KG + DL |
| 28 | palmar fibromatosis | KG + DL |
| 29 | cold agglutinin disease | KG + DL |
| 30 | cyclic hematopoiesis | KG + DL |
| 31 | primary hypereosinophilic syndrome | KG + DL |
| 32 | anorectal stricture | KG + DL |
| 33 | serpinopathy with toxic serpin polymerization | KG + DL |
| 34 | anal polyp | KG + DL |
| 35 | secondary hypereosinophilic syndrome | KG + DL |
| 36 | C1 inhibitor deficiency | KG + DL |
| 37 | X-linked severe congenital neutropenia | KG + DL |
| 38 | imperforate anus | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.